The Indian drugmaker expects regulatory approval for its vaccine against Covid-19 by June. Efficacy readings from its last stage of clinical trials are expected in May.
Cadila is looking to hire contract manufacturers for additional 50-70 million doses of its vaccine, on top of 100 million that will come from its own capacity.
The private lender's shares tumbled to be top Nifty 50 loser after India's central bank barred it from taking on new customers through online and mobile banking channels.
A next generation extended stand-off air-to-surface missile test fired by IAF, ROCKS has been designed & manufactured by Israeli defence major Rafael, keeping India’s needs in mind.
COMMENTS